Cancer Letters
Издатель: Elsevier · ISSN 0304-3835 · 51 статей
- Extracellular vesicle–mediated strategies for cancer tissue normalisation
- Immune checkpoint inhibitor therapy in COPD-concomitant lung cancer: A review of efficacy outcomes and mechanistic insights
- Targeting CDC7 overcomes gemcitabine resistance in cholangiocarcinoma by inducing cellular senescence
- Erianin targets glutathione reductase to trigger immunogenic cell death and sensitize pancreatic cancer to PD-1 blockade
- Lactate-induced PPP1R1B upregulation drives resistance to neoadjuvant immunotherapy in NSCLC via IRF3 dephosphorylation
- Acute MCL1 loss via homoharringtonine-mediated translational inhibition enables potent apoptotic synergy with BCLXL blockade
- Macrophage-derived WNT regulates tumor immune microenvironment to reduce colitis-associated colon cancer
- Combination of canagliflozin and adagrasib as a novel targeted therapy for LKB1-KRASG12C co-mutated NSCLC
- Reprogramming muscle proteostasis in cancer cachexia: Transcriptional mechanisms and therapeutic opportunities
- Aromatase inhibitors beyond hormone-dependent cancers: Mechanisms, preclinical evidence, and emerging clinical applications
- Event-free survival in patients with early triple-negative breast cancer receiving platinum-free, de-escalated anti-PD-1 neoadjuvant therapy: an updated analysis of the NeoTENNIS trial
- Saturation mutagenesis library screening identifies on-target secondary resistance mutations in KRASG12D-selective inhibitors
- SAGE1-mediated H3K27ac enrichment promotes chromatin opening and Fanconi Anemia repair to induce carboplatin resistance in triple-negative breast cancer
- Atovaquone impedes muscle wasting in pancreatic cancer by AMPK modulation
- Metabolic stress rewires DHODH from oncogenesis to SLC7A11-driven disulfidptosis and radiosensitization in esophageal squamous cell carcinoma
- A CD44-regulating multimodal therapeutic strategy for MAFLD-associated pancreatic cancer liver metastasis
- Comprehensive immunoprofiling and multi-omics modeling reveal key immune features associated with disease progression and clinical outcomes in patients with unresectable hepatocellular carcinoma
- The HDAC2/KAT2A-Lamin A lactylation axis regulates tumor progression and chemoresistance in bladder cancer
- Crosstalk between RARγ-driven tumor cells and cancer-associated fibroblasts governs ferroptosis resistance in cholangiocarcinoma
- Comment on the Chinese guidelines for the diagnosis and treatment of pediatric craniopharyngioma (2025)
- Recent advances and future directions in targeting MYCN: From undruggable to druggable